Eidos Therapeutics

DIGITAL & UI/UX


Eidos is a medication focused on amyloid transthyretin cardiomyopathy (ATTR-cm), which causes heart failure in mature adults. As part of Eidos’ new brand identity, I was tasked with creating an informative, clear, and bright website design that would communicate the complexities of ATTR-cm to patients. We also built print materials and a conventional booth for Eidos’ first public appearance in 2020.